Q4 2017
Released Mar 22, 2018, during market hours
10-K filed Mar 28, 2018, 87 days after period end · 0001493152-18-004041
Q4 2017 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$4.15M$4.15M derived+441.2% vs Q4 2016+36.5% vs Q3 2017
Net Income-$217.00K-$217.00K derivedN/M vs Q4 2016N/M vs Q3 2017
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$1,291,000+165.1%
Operating Incomederived-$1,457,000N/M
Operating Cash Flowderived-$1,726,000N/M
Free Cash Flowderived-$1,732,000N/M
Margins · derived
Gross margin31.1%−32.4 pt vs Q4 2016
Operating margin-35.1%−134.3 pt vs Q4 2016
Net margin-5.2%+69.3 pt vs Q4 2016
What the release said
The release
Same quarter
| Metric | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures | Q4 2015 | Q4 2014 |
|---|---|---|---|---|
| Revenue | $4.15M | $767.00K | $8.16M | $8.97M |
| Net Income | -$217.00K | -$572.00K | -$1.26M | -$676.00K |
| EPS Diluted | — | — | -$0.07 | -$0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR